Immedaite vs Early Implant Placement in Aesthetic Area

November 26, 2020 updated by: Algirdas Puisys, DDS, PhD, Vilniaus Implantologijos Centro (VIC) Klinika

Immediate Placement and Temporization of Tapered Implants in Extraction Sockets or Early Implant Placement Protocol? A Randomized Controlled Clinical Trial.

The purpose of this randomized clinical trial, of 50 patients in need of a maxillary anterior implant, was to assess the esthetic outcomes of immediate temporization of immediately placed tapered implants in fresh extraction sockets with soft tissue and bone augmentation as compared to early placed implants with conventional loading. Secondary objectives included the influence of immediate provisionalization on the success rate of tapered implants and crestal bone stability.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

Patients with a failing maxillary anterior tooth were included in this study. After atraumatic extraction, test group patients received an immediate implant with provisional restoration, while patients in the control group received an implant after 6 weeks of healing. After 4 months (test group) and 6 months (control group) definitive restorations were delivered. All patients were followed for 1 year post restoration and pink esthetic score (PES), mid-buccal mucosal level (MBML), crestal bone changes (CBC) and peri-implant soft tissue parameters were recorded at several time points. In addition, patient chair time was recorded.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Vilnius, Lithuania, 10205
        • VIC Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. no recession of gingival contour of tooth to be extracted,
  2. no periodontal bone loss of neighboring anterior teeth,
  3. no implants in neighboring teeth,
  4. class I extraction socket (intact buccal wall),
  5. atraumatic extraction of the tooth with intact socket walls remaining,
  6. only one implant per patient to be inserted.

Exclusion Criteria:

  1. deep bite (severe II class),
  2. systemic disease (diabetes, osteoporosis),
  3. heavy smokers (more than 10 cigarettes/day) were excluded.
  4. atraumatic extraction of the tooth failed,
  5. the primary stability (at least 25 Ncm) needed for implant temporization, after implant placement, was not achieved.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Test group
Test group patients received an immediate implant with provisional restoration, bone augmentation and soft tissue grafting
After tooth extraction implants were placed either immediate or delayed approach
Experimental: Control group
Patients in the control group received soft tissue grafting after tooth extraction and an implant with bone augmentation after 6 weeks of healing.
After tooth extraction implants were placed either immediate or delayed approach

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of pink aesthetic score (PES) over time
Time Frame: Baseline, 1 year and 5 years after prosthetic delivery
pink esthetic score means evaluation of seven parameters of anterior tooth aesthetics - mesial and distal papila, soft tissue level, contour, texture, color and convexity. Each parameter may be evaluated by score 0,1 or 2, were the score 0 means the worst outcome, 2 - the best. Evaluation will be performed visually using digital photos.
Baseline, 1 year and 5 years after prosthetic delivery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of marginal bone level (MBL) around implant neck
Time Frame: Baseline, 1 year and 5 years after prosthetic delivery
Periapical x-rays will be used to measure crestal bone sability distally and mesially of dental implant using certificated x-ray program after calibration. Measurement will be recorded in millimetres from implant neck to the first bone to implant contact
Baseline, 1 year and 5 years after prosthetic delivery
Recession changes of gingiva of restored tooth on the implant
Time Frame: Baseline, 1 year and 5 years after prosthetic delivery
Mid-buccal recession evaluation will be performed using standardised periodontal probe. Measurement of the crown hight will be done in the middle of the tooth from incisal edge to the highest point and recorded in millimetres.
Baseline, 1 year and 5 years after prosthetic delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2017

Primary Completion (Actual)

January 10, 2020

Study Completion (Anticipated)

January 10, 2030

Study Registration Dates

First Submitted

November 19, 2020

First Submitted That Met QC Criteria

November 26, 2020

First Posted (Actual)

December 4, 2020

Study Record Updates

Last Update Posted (Actual)

December 4, 2020

Last Update Submitted That Met QC Criteria

November 26, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • IIS0816

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is no plan to share IPD

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Single Implant; Immediate Implant Treatment; Early Implant Treatment

Clinical Trials on Implant placement

3
Subscribe